Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teresa Kaserer

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Cell Chemical Biology|August 28, 2018
Combining Mutational Signatures, Clonal Fitness, and Drug Affinity to Define Drug-Specific Resistance Mutations in CancerTeresa Kaserer, Julian Blagg
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|September 13, 2022
RESISTOR: A New OSPREY Module to Predict Resistance MutationsNathan Guerin, Teresa Kaserer, Bruce R Donald
STAR Protocols|April 28, 2023
Protocol for predicting drug-resistant protein mutations to an ERK2 inhibitor using RESISTORNathan Guerin, Teresa Kaserer, Bruce R Donald
British Journal of Pharmacology|February 14, 2023
Ca<sub>v</sub> 1.3-selective inhibitors of voltage-gated L-type Ca<sup>2+</sup> channels: Fact or (still) fiction?Ludovica Filippini, Nadine J Ortner, Teresa Kaserer, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 14, 2017
Virtual screening applications in short-chain dehydrogenase/reductase researchKatharina R Beck, Teresa Kaserer, Daniela Schuster, et al.
Pflugers Archiv : European Journal of Physiology|July 16, 2020
Correction to: De novo CACNA1D Ca<sup>2+</sup> channelopathies: clinical phenotypes and molecular mechanismNadine J Ortner, Teresa Kaserer, J Nathan Copeland, et al.
Pflugers Archiv : European Journal of Physiology|June 26, 2020
De novo CACNA1D Ca<sup>2+</sup> channelopathies: clinical phenotypes and molecular mechanismNadine J Ortner, Teresa Kaserer, J Nathan Copeland, et al.
Scientific Reports|February 19, 2016
μ Opioid receptor: novel antagonists and structural modelingTeresa Kaserer, Aquilino Lantero, Helmut Schmidhammer, et al.
Molecules (Basel, Switzerland)|December 26, 2015
Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid DehydrogenasesTeresa Kaserer, Katharina R Beck, Muhammad Akram, et al.
Cell Systems|October 20, 2022
Resistor: An algorithm for predicting resistance mutations via Pareto optimization over multistate protein design and mutational signaturesNathan Guerin, Andreas Feichtner, Eduard Stefan, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Cell Chemical Biology|August 28, 2018
Combining Mutational Signatures, Clonal Fitness, and Drug Affinity to Define Drug-Specific Resistance Mutations in CancerTeresa Kaserer, Julian Blagg
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|September 13, 2022
RESISTOR: A New OSPREY Module to Predict Resistance MutationsNathan Guerin, Teresa Kaserer, Bruce R Donald
STAR Protocols|April 28, 2023
Protocol for predicting drug-resistant protein mutations to an ERK2 inhibitor using RESISTORNathan Guerin, Teresa Kaserer, Bruce R Donald
British Journal of Pharmacology|February 14, 2023
Ca<sub>v</sub> 1.3-selective inhibitors of voltage-gated L-type Ca<sup>2+</sup> channels: Fact or (still) fiction?Ludovica Filippini, Nadine J Ortner, Teresa Kaserer, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 14, 2017
Virtual screening applications in short-chain dehydrogenase/reductase researchKatharina R Beck, Teresa Kaserer, Daniela Schuster, et al.
Pflugers Archiv : European Journal of Physiology|July 16, 2020
Correction to: De novo CACNA1D Ca<sup>2+</sup> channelopathies: clinical phenotypes and molecular mechanismNadine J Ortner, Teresa Kaserer, J Nathan Copeland, et al.
Pflugers Archiv : European Journal of Physiology|June 26, 2020
De novo CACNA1D Ca<sup>2+</sup> channelopathies: clinical phenotypes and molecular mechanismNadine J Ortner, Teresa Kaserer, J Nathan Copeland, et al.
Scientific Reports|February 19, 2016
μ Opioid receptor: novel antagonists and structural modelingTeresa Kaserer, Aquilino Lantero, Helmut Schmidhammer, et al.
Molecules (Basel, Switzerland)|December 26, 2015
Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid DehydrogenasesTeresa Kaserer, Katharina R Beck, Muhammad Akram, et al.
Cell Systems|October 20, 2022
Resistor: An algorithm for predicting resistance mutations via Pareto optimization over multistate protein design and mutational signaturesNathan Guerin, Andreas Feichtner, Eduard Stefan, et al.
Pageof 4